Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Q3 2025 saw a number of exciting approvals and data on promising therapies in development.

Q3 2025 Recap: Rheumatology News and Updates

Q3 2025 saw several new first targeted therapies for rare and more individualized indications in a number of fields.

Q3 2025 Recap: 7 Top FDA Approvals to Know

The rheumatology month in review emphasizes new approvals and the latest comparative research.

7 Rheumatology Headlines You Missed in September 2025

Mease discussed his hopes for the new approval's impact on the fibromyalgia field.

Addressing Fibromyalgia Sleep and Pain With TNX-102 SL Approval: Q&A With Philip Mease, MD

Study data favored the placebo group, although differences were not clinically meaningful.

Cannabidiol Not an Effective Analgesic for Fibromyalgia in Single-Center Study

Zangoglia shared advantages physical therapies may offer in treating people with fibromyalgia.

Exploring Physical Therapy’s Role in Fibromyalgia Care, With Nicole Zangoglia, PT, DPT

TNX-102 SL Data Supports Recent Fibromyalgia Approval 

The rheumatology month in review emphasizes new approvals and best-in-class efficacy data.

7 Rheumatology Headlines You Missed in August 2025

This FDA News Month in Review provides a round-up of regulatory decisions from August 2025.

8 FDA Headlines You Missed in August 2025

The therapy, marketed as Tonmya, is a sublingual formulation of cyclobenzaprine HCl.

FDA Approves TNX-102 SL, First New Fibromyalgia Therapy in 15 Years

On the HCPLive fibromyalgia page, resources on the topics of medical news and expert insight into fibrositis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on fibromyalgia, and more.